Pharmacological Optimization for Successful Traumatic Brain Injury Drug Development.

Journal of Neurotrauma
Samuel M PoloyacPunit Marathe

Abstract

The purpose of this review is to highlight the pharmacological barrier to drug development for traumatic brain injury (TBI) and to discuss best practice strategies to overcome such barriers. Specifically, this article will review the pharmacological considerations of moving from the disease target "hit" to the "lead" compound with drug-like and central nervous system (CNS) penetrant properties. In vitro assessment of drug-like properties will be detailed, followed by pre-clinical studies to ensure adequate pharmacokinetic and pharmacodynamic characteristics of response. The importance of biomarker development and utilization in both pre-clinical and clinical studies will be detailed, along with the importance of identifying diagnostic, pharmacodynamic/response, and prognostic biomarkers of injury type or severity, drug target engagement, and disease progression. This review will detail the important considerations in determining in vivo pre-clinical dose selection, as well as cross-species and human equivalent dose selection. Specific use of allometric scaling, pharmacokinetic and pharmacodynamic criteria, as well as incorporation of biomarker assessments in human dose selection for clinical trial design will also be discussed....Continue Reading

References

Mar 27, 2001·Annual Review of Pharmacology and Toxicology·S J Lee, B S McEwen
Jun 20, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Thorir D BjornssonUNKNOWN FDA Center for Drug Evaluation and Research (CDER)
Mar 3, 2004·Proceedings of the National Academy of Sciences of the United States of America·Tsuyoshi MikkaichiTakaaki Abe
Feb 21, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Hassan Pajouhesh, George R Lenz
Jan 6, 2007·Stroke; a Journal of Cerebral Circulation·Emily SenaMalcolm Macleod
May 2, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Tomohiro NishimuraAkira Tsuji
Sep 14, 2007·Journal of Pharmaceutical Sciences·Hiroshi Komura, Masahiro Iwaki
Oct 24, 2007·Current Topics in Developmental Biology·Daniel E WestholmGrant W Anderson
Sep 19, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Levi L Blazer, Richard R Neubig
Sep 15, 2009·Current Topics in Medicinal Chemistry·Gary W CaldwellBecki Hasting
Oct 20, 2010·Expert Opinion on Drug Metabolism & Toxicology·Odette A Fahmi, Sharon L Ripp
Nov 6, 2010·Nature Medicine·Steven Finkbeiner
Nov 26, 2010·British Journal of Pharmacology·J P HughesK L Philpott
Nov 8, 2011·Drug Discovery Today·Hongmao SunAnders Wallqvist
Jan 24, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Guangqing XiaoLiang-Shang L Gan
Feb 19, 2014·Regulatory Toxicology and Pharmacology : RTP·Iftekhar Mahmood, Harold Boxenbaum
Jun 24, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Xiang YiAlexander V Kabanov
Feb 12, 2015·Clinical Pharmacology and Therapeutics·W M Pardridge
Jun 11, 2015·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Jafar Sadik B ShaikMioara D Manole
Dec 17, 2015·Journal of Neurotrauma·Megan BrowningPatrick M Kochanek
Jun 5, 2016·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Iain J MartinErin F Mulrooney
Jun 10, 2016·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Fanuel T HagosPhilip E Empey
Aug 31, 2016·Annual Review of Pharmacology and Toxicology·P H HutsonA J Cross
Nov 24, 2016·Neuroscience Research·Nao J GamoAkira Sawa
May 5, 2017·Journal of Central Nervous System Disease·Kunal S TaskarSandhya Mandlekar

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
nuclear magnetic resonance
gene knockout

Software Mentioned

BEST ( Biomarkers , EndpointS , and other Tools )

Related Concepts

Related Feeds

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.